Myocardial Deformation in Cardiac Amyloid Light-chain Amyloidosis: Assessed with 3T Cardiovascular Magnetic Resonance Feature Tracking
Abstract Clinically, assessment of myocardial function is essential in patients with amyloid light-chain cardiac amyloidosis (AL-CA) to predict outcome and determine therapeutic approach. The aim of this study was to investigate the feasibility of cardiovascular magnetic resonance (CMR)-derived feat...
Guardado en:
Autores principales: | Rui Li, Zhi-gang Yang, Hua-yan Xu, Ke Shi, Xi Liu, Kai-yue Diao, Ying-kun Guo |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/346e80f1e9b741c6b188d16b98f8e172 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Cryo-EM structure of cardiac amyloid fibrils from an immunoglobulin light chain AL amyloidosis patient
por: Paolo Swuec, et al.
Publicado: (2019) -
Light-chain cardiac amyloidosis with neuropathy: a case report
por: Xu ZW, et al.
Publicado: (2015) -
Differences in the characteristics and contemporary cardiac outcomes of patients with light-chain versus transthyretin cardiac amyloidosis.
por: Osnat Itzhaki Ben Zadok, et al.
Publicado: (2021) -
Retinitis pigmentosa associated with systemic light chain amyloidosis (AL amyloidosis)
por: Salem Bouomrani, et al.
Publicado: (2021) -
Dexamethasone is associated with early deaths in light chain amyloidosis patients with severe cardiac involvement.
por: Mélanie Bézard, et al.
Publicado: (2021)